Network-based stratification of tumor mutations
暂无分享,去创建一个
[1] C. Waddington. Canalization of Development and the Inheritance of Acquired Characters , 1942, Nature.
[2] William M. Rand,et al. Objective Criteria for the Evaluation of Clustering Methods , 1971 .
[3] C. K. Yuen,et al. Theory and Application of Digital Signal Processing , 1978, IEEE Transactions on Systems, Man, and Cybernetics.
[4] R. Gill,et al. Cox's regression model for counting processes: a large sample study : (preprint) , 1982 .
[5] H. Sebastian Seung,et al. Learning the parts of objects by non-negative matrix factorization , 1999, Nature.
[6] B. Strauss. Role in tumorigenesis of silent mutations in the TP53 gene. , 2000, Mutation research.
[7] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[9] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] Jill P. Mesirov,et al. Consensus Clustering: A Resampling-Based Method for Class Discovery and Visualization of Gene Expression Microarray Data , 2003, Machine Learning.
[11] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[12] Pablo Tamayo,et al. Metagenes and molecular pattern discovery using matrix factorization , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[13] Kevin Coombes,et al. Prognostic Role of a Multigene Reverse Transcriptase-PCR Assay in Patients with Node-Negative Breast Cancer Not Receiving Adjuvant Systemic Therapy , 2005, Clinical Cancer Research.
[14] T J Hudson,et al. Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer , 2006, British Journal of Cancer.
[15] Lippincott-Schwartz,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page , 2022 .
[16] Ross S Berkowitz,et al. Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[18] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[19] R. Tothill,et al. Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.
[20] Jiawei Han,et al. Non-negative Matrix Factorization on Manifold , 2008, 2008 Eighth IEEE International Conference on Data Mining.
[21] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[22] Laurent Ozbun,et al. A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer. , 2008, Cancer research.
[23] S. Cannistra,et al. Gene-expression profiling in epithelial ovarian cancer , 2008, Nature Clinical Practice Oncology.
[24] Weixiong Zhang,et al. Identifying network communities with a high resolution. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.
[25] Michael O Dorschner,et al. Sequencing newly replicated DNA reveals widespread plasticity in human replication timing , 2009, Proceedings of the National Academy of Sciences.
[26] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[27] Kenneth H. Buetow,et al. PID: the Pathway Interaction Database , 2008, Nucleic Acids Res..
[28] M. Somerfield,et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] J. Stamatoyannopoulos,et al. Human mutation rate associated with DNA replication timing , 2009, Nature Genetics.
[30] Pamela K. Kreeger,et al. Cancer systems biology: a network modeling perspective , 2009, Carcinogenesis.
[31] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[32] David Haussler,et al. Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..
[33] Caroline Dive,et al. Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer , 2010, Cancer biology & therapy.
[34] klaguia. International Network of Cancer Genome Projects , 2010 .
[35] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[36] N. Turner,et al. Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.
[37] Roded Sharan,et al. Associating Genes and Protein Complexes with Disease via Network Propagation , 2010, PLoS Comput. Biol..
[38] B. Karlan,et al. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] Trey Ideker,et al. Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..
[40] C. Sander,et al. Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.
[41] J. Weidhaas,et al. miRNAs in the spotlight: Making 'silent' mutations speak up , 2011, Nature Medicine.
[42] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[43] C. Kimchi-Sarfaty,et al. Understanding the contribution of synonymous mutations to human disease , 2011, Nature Reviews Genetics.
[44] A. Cheema,et al. Small Changes Huge Impact: The Role of Protein Posttranslational Modifications in Cellular Homeostasis and Disease , 2011, Journal of amino acids.
[45] Eli Upfal,et al. Algorithms for Detecting Significantly Mutated Pathways in Cancer , 2010, RECOMB.
[46] Gary D. Bader,et al. Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..
[47] K. Wilson,et al. The nucleoskeleton as a genome-associated dynamic 'network of networks' , 2011, Nature Reviews Molecular Cell Biology.
[48] E. Marcotte,et al. Prioritizing candidate disease genes by network-based boosting of genome-wide association data. , 2011, Genome research.
[49] Trey Ideker,et al. Protein Networks as Logic Functions in Development and Cancer , 2011, PLoS Comput. Biol..
[50] L. Pusztai,et al. Gene expression profiling in breast cancer: classification, prognostication, and prediction , 2011, The Lancet.
[51] Zhengyan Kan,et al. Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.
[52] Damian Szklarczyk,et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored , 2010, Nucleic Acids Res..
[53] K. Hess,et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. , 2011, JAMA.
[54] Jannik N. Andersen,et al. Cancer genomics: from discovery science to personalized medicine , 2011, Nature Medicine.
[55] Jay W. Wright,et al. BRCAness Profile of Sporadic Ovarian Cancer Predicts Disease Recurrence , 2012, PloS one.
[56] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[57] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[58] Michael R. Hayden,et al. Whole-Genome Sequencing: The New Standard of Care? , 2012, Science.
[59] M. Roizen,et al. Hallmarks of Cancer: The Next Generation , 2012 .
[60] E. Mardis. Genome sequencing and cancer. , 2012, Current opinion in genetics & development.
[61] G. Berx,et al. Gene expression profiling to dissect the complexity of cancer biology: pitfalls and promise. , 2012, Seminars in cancer biology.
[62] Z. Szallasi,et al. Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian-cancer using microarray data from 1287 patients. , 2012, Endocrine-related cancer.
[63] P. Stenson,et al. The Human Gene Mutation Database (HGMD) and Its Exploitation in the Fields of Personalized Genomics and Molecular Evolution , 2012, Current protocols in bioinformatics.
[64] Ilya Shmulevich,et al. Integrated Analysis of Gene Expression and Tumor Nuclear Image Profiles Associated with Chemotherapy Response in Serous Ovarian Carcinoma , 2012, PloS one.
[65] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumors , 2012, Nature.
[66] A. McKenna,et al. Exome and whole genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity , 2013, Nature Genetics.
[67] H. Carter,et al. Identifying Mendelian disease genes with the Variant Effect Scoring Tool , 2013, BMC Genomics.
[68] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[69] Steven J. M. Jones,et al. Comprehensive molecular portraits of human breast tumours , 2013 .
[70] Hannah Carter,et al. CRAVAT: cancer-related analysis of variants toolkit , 2013, Bioinform..
[71] Steven A. Roberts,et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .
[72] K. Cibulskis,et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. , 2012, The Journal of clinical investigation.
[73] Steven J. M. Jones,et al. Integrated genomic characterization of endometrial carcinoma , 2013, Nature.
[74] G. Barry,et al. The emerging role of RNA and DNA editing in cancer. , 2014, Biochimica et biophysica acta.